Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.
Saved in:
| Title: | Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial. |
|---|---|
| Authors: | Low PA; Mayo Clinic, Rochester, MN, USA. Electronic address: low@mayo.edu., Robertson D; Vanderbilt University, Nashville, TN, USA., Gilman S; University of Michigan, Ann Arbor, MI, USA., Kaufmann H; New York University Medical Center, New York, NY, USA., Singer W; Mayo Clinic, Rochester, MN, USA., Biaggioni I; Vanderbilt University, Nashville, TN, USA., Freeman R; Beth Israel Deaconess Medical Center, Boston, MA, USA., Perlman S; University of California, Los Angeles Medical Center, Los Angeles, CA, USA., Hauser RA; University of South Florida, Tampa, FL, USA., Cheshire W; Mayo Clinic, Jacksonville, FL, USA., Lessig S; University of California, San Diego, La Jolla, CA, USA., Vernino S; University of Texas Southwestern Medical Center, Dallas, TX, USA., Mandrekar J; Mayo Clinic, Rochester, MN, USA., Dupont WD; Vanderbilt University, Nashville, TN, USA., Chelimsky T; Medical College of Wisconsin, Milwaukee, WI, USA., Galpern WR; National Institutes of Health, Bethesda, MD, USA. |
| Source: | The Lancet. Neurology [Lancet Neurol] 2014 Mar; Vol. 13 (3), pp. 268-75. Date of Electronic Publication: 2014 Feb 05. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
